The results showed that SGRh2 dose-dependently attenuated the expression of MMP-2 and MMP-9 in CRC cells (Figure 4C), indicating that SGRh2 affected the migration and invasion of CRC cells through a downregulation of MMP-2 and MMP-9 expression. Here, MMP2 is linked to colorectal carcinoma.